Mark Richard Rosenzweig

机构：Blueprint Medicines (United States) · ORCID：0000-0002-6323-1418

发表论文 747 篇 · 总被引 53751 次 · h-index 119

代表论文

• Are There Too Many Farms in the World? Labor Market Transaction Costs, Machine Capacities, and Optimal Farm Size (2021 · Journal of Political Economy · 被引 193)
• External Validity in a Stochastic World: Evidence from Low-Income Countries (2019 · The Review of Economic Studies · 被引 94)
• Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA (2020 · Oncology · 被引 63)
• Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns (2021 · JCO Precision Oncology · 被引 51)
• Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers (2020 · The Oncologist · 被引 31)
• Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib (2019 · Molecular Case Studies · 被引 22)